AACR Special Conference: Fusion-Positive Cancer: From Discovery to Therapy

Hosted by the American Association for Cancer Research (AACR), the AACR Special Conference on Fusion-Positive Cancers 2026 will bring together leading researchers, clinicians, and translational scientists to discuss the latest advances in fusion oncogene biology, carcinogenesis, and targeted therapeutic strategies. This premier event will explore the genetic and molecular mechanisms driving fusion-driven malignancies, highlighting key topics such as tumor modeling, condensate biology, gene regulatory networks, and novel therapeutic approaches, including small molecule inhibitors, targeted protein degradation, and CRISPR-based technologies. Through plenary sessions, keynote lectures, and poster presentations, attendees will engage in discussions on how cutting-edge research is shaping the future of fusion-positive cancer diagnosis and treatment.